Cryopreserved Leukopaks: Addressing the Viability Myth

Cryopreserved Leukopaks: Addressing the Viability Myth

Recent publications, including a landmark paper from Novartis¹, demonstrate the viability and utility of cryopreserved leukopaks, dispelling the viability myth.
Read More
Addressing the Achilles Heel of T-Cell Therapy

Addressing the Achilles Heel of T-Cell Therapy

Cryopreserved leukopaks eliminate the constraints imposed by a reliance on fresh human cells for T-cell therapies. Has the tide turned in favor of frozen cells?
Read More
Discovery Celebrates Women’s History Month

Discovery Celebrates Women’s History Month

This March 2022, while we celebrate Women’s History Month, we pay tribute to women whose incredible achievements have advanced science, medicine, and technology.  The National Women’s History Alliance’s theme for this ...
Read More
Overcoming Logistical Challenges to Sourcing Fresh Tissue in a Post-COVID-19 Environment

Overcoming Logistical Challenges to Sourcing Fresh Tissue in a Post-COVID-19 Environment

Access to highly-annotated primary human tissues is an integral part of precision medicine research and development, but the logistical barriers of acquiring fresh tissue have persisted over many decades. These logistical ...
Read More

How HER2 Evolved As A Companion Diagnostic For Breast Cancer Treatment

Breast cancer affects millions of women worldwide and is the most commonly occurring cancer in women. While there are many different types of breast cancer, roughly 20% of all cases are ...
Read More

How The Right Biomarker Strategy Can Significantly Increase Your Clinical Trials Success Rate

According to a recent peer-reviewed paper published in the journal of Cancer Medicine, the clinical trial failure rates for drugs treating major cancer types (non-small cell lung cancer, metastatic melanoma, non-Hodgkin’s ...
Read More
Overcoming Challenges To Effectively Leverage Genomic Biomarkers In Precision Oncology

Overcoming Challenges To Effectively Leverage Genomic Biomarkers In Precision Oncology

Read More

Make Confident Strategic Decisions Using Our Global Tissue Biomarker Services in Your Clinical Trials

Strategy has become more important than ever when it comes to planning and executing global clinical trials given the quickly changing, unpredictable circumstances of the last year. These clinical trials are ...
Read More

Could Rapid Tests Be The Practical Way To Help Europe Safely Reopen?

Nearly a year after the first infection, much of Europe still remains under tough restrictions, as countries extend their lockdowns into Easter and further into April. Meanwhile, a third wave of ...
Read More

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image